Glenmark Pharmaceuticals Ltd Sustainability Reports

A research-driven, global, integrated pharmaceutical company focusing on generics, specialty, and OTC products, with key expertise in dermatology, respiratory, and oncology therapies.

Sector: Manufacturing

Country: India

Exchange: National Stock Exchange of India

LEI: 335800WKECZXIIT9GK20

FIGI: BBG001S8KJ87

28 reports from 2011 to 2026

• Glenmark Pharmaceuticals Ltd 2026 Integrated Annual Report
• Glenmark Pharmaceuticals Ltd 2025 Taskforce on Nature-related Financial Disclosures (TNFD) Report
• Glenmark Pharmaceuticals Ltd 2025 Integrated Annual Report
• Glenmark Pharmaceuticals Ltd 2025 ESG Factbook
• Glenmark Pharmaceuticals Ltd 2024 ESG Factbook